Peter Ellmark
Company: Alligator Bioscience AB
Job title: Chief Science Officer
Seminars:
Clinical Case Study: CD40-Mediated Activation of Myeloid Cells to Drive Anti-Tumor Immunity to Enhance the Overall Anti-Tumor Effects 9:30 am
CD40-mediated activation of myeloid cells is a promising approach for enhancing antitumor immunity CD40-mediated activation directs the immune system toward recognizing and attacking tumor-specific antigens CD40-mediated activation can synergize with existing cancer therapies, combinatorial approaches with checkpoint inhibitors or chemotherapy enhance overall anti-tumor effectsRead more
day: Conference Day 2